William E. Dager, Pharm.D., BCPS (AQ-Cardiology), is a cardiovascular pharmacist specialist in at UC Davis Medical Center and is the PGY-2 cardiology program director. Dr. Dager holds two academic positions and four fellowship honors and is a board certified pharmacotherapy specialist with added qualifications in cardiology. He one of only a few pharmacists recognized as a Master in Critical Care Medicine. After graduation from UCSF, he completed a residency at UC Davis Medical Center and Nephrology Pharmaceutical Care Preceptorship at the University of Pittsburgh.
Dr. Dager's research interests focus on anticoagulation, critical care medicine, cardiovascular disease, and pharmacokinetics and pharmacodynamics. He has authored over 125 articles, book chapters, and scientific reviews, and co-edited as well as authored several chapters in “Anticoagulation Therapy: A Point-of-care Guide” publishedby ASHP in 2011 and second edition in 2018. He also currently is serving as a panel member for the CHEST 10thedition Antithrombotic therapy Guidelines.
Dr. Dager has received multiple teaching and professional awards, including the 2008 American Collegeof Clinical Pharmacy Best Practice Award and Master of Critical Care Medicine from The Society of Critical Care Medicine. In 2019, he was the SCCM Congress Co-Chair. In 2018 he was re-elected to a second term Board of Reagents of the American College of Critical Care Medicine. In 2019 he was selected to be on the Anticoagulation Forum Board of Directors.